CareDx (CDNA) Tops Q2 EPS by 65c ; Offers Guidance

CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.25, $0.65 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $92.3 million versus the consensus estimate of $67.85 million.

GUIDANCE:

CareDx sees FY2024 revenue of $320-328 million, versus the consensus of $279 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Evolution Petroleum to buy Midland Basin mineral rights for $16M
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance